Inhaled insulin for diabetes mellitus.
暂无分享,去创建一个
[1] W. Cefalu,et al. Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study , 2001, The Lancet.
[2] R. Kinget,et al. The lung as a route for systemic delivery of therapeutic proteins and peptides , 2001, Respiratory research.
[3] L. Heinemann,et al. Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery. , 2002, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[4] R. Langer,et al. Large Porous Particles for Sustained Protection from Carbachol-Induced Bronchoconstriction in Guinea Pigs , 1999, Pharmaceutical Research.
[5] A. Himmelmann,et al. The impact of smoking on inhaled insulin. , 2003, Diabetes care.
[6] P. Iglesias,et al. Inhaled insulin – a new therapeutic option in the treatment of diabetes mellitus , 2003, Expert opinion on pharmacotherapy.
[7] W. Cefalu. Concept, strategies, and feasibility of noninvasive insulin delivery. , 2004, Diabetes care.
[8] D R Owens,et al. Monomeric Insulins and Their Experimental and Clinical Implications , 1990, Diabetes Care.
[9] J. B. Collip,et al. Pancreatic extracts in the treatment of diabetes mellitus: preliminary report. 1922. , 1991, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[10] J. Palmer,et al. Inhaled insulin and insulin antibodies: a new twist to an old debate. , 2002, Diabetes technology & therapeutics.
[11] J. Rosenstock,et al. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen. , 2002, Clinical therapeutics.
[12] T. Quattrin,et al. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. , 2004, Diabetes care.
[13] J. Selam. Inhaled insulin for the treatment of diabetes: projects and devices , 2003, Expert opinion on pharmacotherapy.
[14] W. Cefalu,et al. Inhaled Human Insulin Treatment in Patients with Type 2 Diabetes Mellitus , 2001, Annals of Internal Medicine.
[15] A. Dobs,et al. The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes. , 1998, Chest.
[16] B. Laube. Treating diabetes with aerosolized insulin. , 2001, Chest.
[17] S. Davis,et al. Pharmacokinetics and Acute Safety of Inhaled Testosterone in Postmenopausal Women , 2005, Journal of clinical pharmacology.
[18] L. Heinemann,et al. Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetes. , 2002, Diabetes care.
[19] Lawrence Blonde,et al. Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial. , 2004, Diabetes care.
[20] N Lotan,et al. Large porous particles for pulmonary drug delivery. , 1997, Science.
[21] K. Nair,et al. Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. , 2003, Diabetes.
[22] R. Langer,et al. Recent advances in pulmonary drug delivery using large, porous inhaled particles. , 1998, Journal of applied physiology.
[23] Lutz Heinemann,et al. Variability of insulin absorption and insulin action. , 2002, Diabetes technology & therapeutics.